Skip to main content
. 2020 Jul 1;183(1):G9–G15. doi: 10.1530/EJE-20-0338

Table 1.

Risks and protective measures in DI and hyponatremia in times of COVID-19.

Risks Protective measures
Diabetes insipidus Dilutational hyponatraemia as side effect of desmopressin therapy Delay desmopressin dose once or twice weekly; Advise to regularly control body weight
Drink to thirst
High risk for dysnatraemia if admitted to the hospital due to missed desmopressin dose, reduced fluid intake, increased insensible losses and the potential need for diuretic therapy Endocrine consultation for every patient with DI to reduce prescribing errors and to advise with fluid management
Patient empowerment
Appropriate stress dosing of corticosteroids in patients with additional ACTH deficiency
Hyponatraemia New diagnosis of SIAD after neurosurgical interventions, brain injury or subarachnoid hemorrhage Advise to limit fluid intake for two weeks following surgery / injury
Measure body weight daily and aim to stay at eunatraemic weight
Drink only to thirst
Know the early symptoms of hyponatraemia